USPTO serial 79219041
DORIA
Reviewed by CopyMark Law Group
Reg. 5477992Status 709
- Filing date
- Status date
- Registration date
- May 29, 2018
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DORIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LABORATORIOS FARMACEUTICOS ROVI, S.A.
ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
LABORATORIOS FARMACEUTICOS ROVI, S.A.
ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
LABORATORIOS FARMACEUTICOS ROVI, S.A.
ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin Hartley
Kevin Hartley Trust Tree Legal, P.C.798 Berry Road #41400Nashville, TN 37204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, chemical-pharmaceuticals for the treatment of central nervous system diseases, namely, psychosis, anxiety and schizophrenia; pharmaceuticals, namely, anxiolytics, antipsychotics; syringes for medical purposes sold filled with pharmaceuticals for treating psychosis, anxiety and schizophrenia; vials for medical purposes sold filled with pharmaceuticals for treating psychosis, anxiety and schizophrenia; cartridges sold filled with pharmaceuticals for treating schizophrenia; ampules sold filled with pharmaceuticals for the treatment of psychosis, anxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceutical preparations for psychosis, anxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceuticals for sustained release of medicines for treating psychosis, anxiety and schizophrenia; preparations for the treatment of central nervous system diseases; preparations for the treatment of psychosis, anxiety and schizophrenia; sanitary preparations for medical use; dietetic foods adapted for medical use; dietary supplements for humans; plasters for medical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks in Class 005
- Similar marks named DORIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 1, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 1, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 13, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 13, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 29, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 8, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 13, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 13, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 29, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 29, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 26, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 17, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 16, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 10, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 10, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 10, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 1, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 17, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 17, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 13, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 3, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 2, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |